[The concept of protection in anesthesiology].
D000138:Acidosis / Q000517:prevention & control; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000367:Age Factors; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use; D000758:Anesthesia / Q000009:adverse effects*; D002090:Butyrophenones / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control; D002395:Catecholamines / Q000378:metabolism; D004877:Ergoloid Mesylates / Q000627:therapeutic use; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy / Q000517:prevention & control*; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D000860:Hypoxia / Q000517:prevention & control*; D017053:Infection Control; D007328:Insulin / Q000627:therapeutic use; D008099:Liver / Q000201:enzymology; D008107:Liver Diseases / Q000517:prevention & control; D008297:Male; D008659:Metabolic Diseases / Q000517:prevention & control*; D011395:Promazine / Q000008:administration & dosage / Q000627:therapeutic use; D012151:Resuscitation; D012769:Shock / Q000517:prevention & control; D013268:Stimulation, Chemical; D014652:Vascular Diseases / Q000517:prevention & control; D014815:Vitamins / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D002090:Butyrophenones; D002395:Catecholamines; D007328:Insulin; D014815:Vitamins; D004877:Ergoloid Mesylates; D005947:Glucose; D011395:Promazine
La notion de protection en anesthésiologie.